Ana‐Maria Orbai

10.8k total citations
114 papers, 1.6k citations indexed

About

Ana‐Maria Orbai is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Ana‐Maria Orbai has authored 114 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Rheumatology, 60 papers in Immunology and 58 papers in Hematology. Recurrent topics in Ana‐Maria Orbai's work include Spondyloarthritis Studies and Treatments (80 papers), Autoimmune and Inflammatory Disorders Research (58 papers) and Psoriasis: Treatment and Pathogenesis (58 papers). Ana‐Maria Orbai is often cited by papers focused on Spondyloarthritis Studies and Treatments (80 papers), Autoimmune and Inflammatory Disorders Research (58 papers) and Psoriasis: Treatment and Pathogenesis (58 papers). Ana‐Maria Orbai collaborates with scholars based in United States, Canada and United Kingdom. Ana‐Maria Orbai's co-authors include Clifton O. Bingham, Susan J. Bartlett, Alexis Ogdie, Dafna D. Gladman, Victoria Ruffing, Laura C. Coates, Philip J. Mease, William Tillett, Ying Ying Leung and Vivian P. Bykerk and has published in prestigious journals such as Circulation, PLoS ONE and The American Journal of Medicine.

In The Last Decade

Ana‐Maria Orbai

107 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana‐Maria Orbai United States	23	1.1k	633	632	164	142	114	1.6k
Kunal K. Gandhi United States	20	584 0.5×	496 0.8×	576 0.9×	138 0.8×	199 1.4×	61	1.8k
Anneke Spoorenberg Netherlands	27	2.7k 2.4×	1.3k 2.1×	839 1.3×	108 0.7×	130 0.9×	103	3.1k
Uta Kiltz Germany	24	2.0k 1.8×	1.3k 2.0×	742 1.2×	73 0.4×	120 0.8×	252	2.4k
Isabel Castrejón Spain	22	1.0k 0.9×	216 0.3×	354 0.6×	73 0.4×	179 1.3×	138	1.6k
Alexander Fraser Ireland	19	1.1k 1.0×	329 0.5×	587 0.9×	78 0.5×	209 1.5×	63	1.6k
Ennio Lubrano Italy	32	2.5k 2.3×	1.9k 3.0×	1.1k 1.8×	223 1.4×	115 0.8×	196	3.2k
Michel Zummer Canada	20	1.3k 1.2×	402 0.6×	305 0.5×	116 0.7×	241 1.7×	41	1.8k
Sharon LeClercq Canada	15	768 0.7×	383 0.6×	395 0.6×	130 0.8×	266 1.9×	27	1.4k
Catherine T. Schentag Canada	26	1.6k 1.5×	1.4k 2.1×	825 1.3×	207 1.3×	131 0.9×	34	2.2k
M.C.W. Creemers Netherlands	18	1.2k 1.1×	532 0.8×	357 0.6×	143 0.9×	245 1.7×	29	1.7k

Countries citing papers authored by Ana‐Maria Orbai

Since Specialization

Citations

This map shows the geographic impact of Ana‐Maria Orbai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana‐Maria Orbai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana‐Maria Orbai more than expected).

Fields of papers citing papers by Ana‐Maria Orbai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana‐Maria Orbai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana‐Maria Orbai. The network helps show where Ana‐Maria Orbai may publish in the future.

Co-authorship network of co-authors of Ana‐Maria Orbai

This figure shows the co-authorship network connecting the top 25 collaborators of Ana‐Maria Orbai. A scholar is included among the top collaborators of Ana‐Maria Orbai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana‐Maria Orbai. Ana‐Maria Orbai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yazji, Salim, Philip Helliwell, Andra Bălănescu, et al.. (2025). Association Between Patient Perception of Disease Status and Different Components of the Minimal Disease Activity Criteria in Psoriatic Arthritis. The Journal of Rheumatology. 52(4). jrheum.2024–1149. 1 indexed citations

Gossec, Laure, Ana‐Maria Orbai, Laura C. Coates, et al.. (2024). Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis. RMD Open. 10(1). e003548–e003548. 1 indexed citations

Leung, Ying Ying, Lihi Eder, Ana‐Maria Orbai, et al.. (2023). Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study. RMD Open. 9(3). e003157–e003157. 7 indexed citations

Orbai, Ana‐Maria, et al.. (2023). Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis. Dermatology and Therapy. 13(11). 2859–2868. 4 indexed citations

Leung, Ying Ying, William Tillett, Ana‐Maria Orbai, et al.. (2023). Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group. The Journal of Rheumatology. 50(Suppl 2). 53–57. 12 indexed citations

Holland, Richard, Ashish Jacob Mathew, Maria Antonietta D’Agostino, et al.. (2022). Plain Radiographic Instruments for Structural Damage in Peripheral Joints in Psoriatic Arthritis: A Report From the GRAPPA-OMERACT Working Group. The Journal of Rheumatology. 49(6 Suppl 1). jrheum.211322–jrheum.211322. 4 indexed citations

Nguyen, Tien N., Melvin Churchill, Robert M. Levin, et al.. (2022). Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study. The Journal of Rheumatology. 49(8). 894–902. 11 indexed citations

Smith, Lauren, Ana‐Maria Orbai, Jemima Albayda, et al.. (2022). Snap, Crackle, and Pop: From a Painful Finger to Progressive Dyspnea to Popping Neck Pain. The American Journal of Medicine. 136(2). 143–146.

Coates, Laura C., Danielle E Robinson, Ana‐Maria Orbai, et al.. (2021). What influences patients’ opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study. Lara D. Veeken. 60(11). 5292–5299. 6 indexed citations

10.

Leung, Ying Ying, William Tillett, Pil Højgaard, et al.. (2021). Test-retest Reliability for HAQ-DI and SF-36 PF for the Measurement of Physical Function in Psoriatic Arthritis. The Journal of Rheumatology. 48(10). 1547–1551. 5 indexed citations

11.

Leung, Ying Ying, Ana‐Maria Orbai, William Tillett, et al.. (2021). Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group. The Journal of Rheumatology. 97. jrheum.201679–jrheum.201679. 2 indexed citations

12.

Leung, Ying Ying, Ana‐Maria Orbai, Alexis Ogdie, et al.. (2020). Appraisal of Candidate Instruments for Assessment of the Physical Function Domain in Patients with Psoriatic Arthritis. The Journal of Rheumatology. 48(1). 58–66. 9 indexed citations

13.

Leung, Ying Ying, William Tillett, Ana‐Maria Orbai, et al.. (2020). The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates. The Journal of Rheumatology. 96. 46–49. 11 indexed citations

14.

Bartlett, Susan J., Kathleen M. Andersen, Vivian P. Bykerk, et al.. (2020). Identifying Minimal and Meaningful Change in a Patient‐Reported Outcomes Measurement Information System for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives. Arthritis Care & Research. 74(4). 588–597. 26 indexed citations

15.

Coates, Laura C., Ana‐Maria Orbai, Valderílio Feijó Azevedo, et al.. (2020). Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire. Health and Quality of Life Outcomes. 18(1). 173–173. 39 indexed citations

16.

Leung, Ying Ying, Ana‐Maria Orbai, Maarten de Wit, et al.. (2020). Comparing the Patient‐Reported Physical Function Outcome Measures in a Real‐Life International Cohort of Patients With Psoriatic Arthritis. Arthritis Care & Research. 73(4). 593–602. 10 indexed citations

17.

Leung, Ying Ying, Ana‐Maria Orbai, Alexis Ogdie, et al.. (2019). The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set. The Journal of Rheumatology. 95. 33–37. 14 indexed citations

18.

Orbai, Ana‐Maria, Alexis Ogdie, Laure Gossec, et al.. (2019). Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR). Lara D. Veeken. 59(7). 1495–1504. 22 indexed citations

19.

Ly, Karen, et al.. (2019). <p>Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives</p>. PubMed. Volume 9. 97–107. 16 indexed citations

20.

Coates, Laura C., Ana‐Maria Orbai, Akimichi Morita, et al.. (2018). Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity. BMC Rheumatology. 2(1). 24–24. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact